TY - JOUR
T1 - Postoperative Enteral Nutrition Guidelines Reduce the Risk of Intestinal Failure–Associated Liver Disease in Surgical Infants
AU - Shores, Darla R.
AU - Alaish, Samuel M.
AU - Aucott, Susan W.
AU - Bullard, Janine E.
AU - Haney, Courtney
AU - Tymann, Heidi
AU - Nonyane, Bareng A.S.
AU - Schwarz, Kathleen B.
N1 - Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018/4
Y1 - 2018/4
N2 - Objective: To assess the effectiveness of postoperative feeding guidelines in reducing the incidence and severity of intestinal failure–associated liver disease (IFALD) among infants. Study design: Two cohorts of infants <6 months old undergoing intestinal surgery were compared: preguideline (retrospective data from 2007 to 2013; n = 83) and postguideline (prospective data from 2013 to 2016; n = 81). The guidelines included greater initial enteral nutrition volumes of 20 mL/kg/d and daily feeding advancement if tolerated. The primary outcomes were incidence of IFALD (peak direct bilirubin [DB] >2 mg/dL) and severity (DB >5 mg/dL for moderate-severe). Multiple logistic regression was used to determine the odds of developing IFALD. Other outcomes were time to reach 50% and 100% goal calories from enteral nutrition and the incidence of necrotizing enterocolitis after feeding. Results: The incidence of IFALD decreased from 71% to 51% (P =.031), and median peak DB decreased from 5.7 to 2.4 mg/dL (P =.001). After adjusting for diagnosis and prematurity, the odds of developing IFALD of any severity were reduced by 60% (OR 0.40, 95% CI 0.20-0.85), and the odds of developing moderate-to-severe IFALD were reduced by 72% (OR 0.28, 95% CI 0.13-0.58) with guideline use. Time to reach 50% enteral nutrition decreased from a median of 10 to 6 days (P =.020) and time to reach 100% enteral nutrition decreased from 35 to 21 days (P =.035) with guideline use. The incidence of necrotizing enterocolitis after initiating enteral nutrition did not change (5% vs 9%, P =.346). Conclusions: Implementation of feeding guidelines reduced time to reach feeding goals, significantly reducing IFALD incidence and severity.
AB - Objective: To assess the effectiveness of postoperative feeding guidelines in reducing the incidence and severity of intestinal failure–associated liver disease (IFALD) among infants. Study design: Two cohorts of infants <6 months old undergoing intestinal surgery were compared: preguideline (retrospective data from 2007 to 2013; n = 83) and postguideline (prospective data from 2013 to 2016; n = 81). The guidelines included greater initial enteral nutrition volumes of 20 mL/kg/d and daily feeding advancement if tolerated. The primary outcomes were incidence of IFALD (peak direct bilirubin [DB] >2 mg/dL) and severity (DB >5 mg/dL for moderate-severe). Multiple logistic regression was used to determine the odds of developing IFALD. Other outcomes were time to reach 50% and 100% goal calories from enteral nutrition and the incidence of necrotizing enterocolitis after feeding. Results: The incidence of IFALD decreased from 71% to 51% (P =.031), and median peak DB decreased from 5.7 to 2.4 mg/dL (P =.001). After adjusting for diagnosis and prematurity, the odds of developing IFALD of any severity were reduced by 60% (OR 0.40, 95% CI 0.20-0.85), and the odds of developing moderate-to-severe IFALD were reduced by 72% (OR 0.28, 95% CI 0.13-0.58) with guideline use. Time to reach 50% enteral nutrition decreased from a median of 10 to 6 days (P =.020) and time to reach 100% enteral nutrition decreased from 35 to 21 days (P =.035) with guideline use. The incidence of necrotizing enterocolitis after initiating enteral nutrition did not change (5% vs 9%, P =.346). Conclusions: Implementation of feeding guidelines reduced time to reach feeding goals, significantly reducing IFALD incidence and severity.
KW - atresia
KW - cholestasis
KW - feeding protocol
KW - gastroschisis
KW - necrotizing enterocolitis
KW - short bowel syndrome
UR - http://www.scopus.com/inward/record.url?scp=85041355511&partnerID=8YFLogxK
U2 - 10.1016/j.jpeds.2017.11.058
DO - 10.1016/j.jpeds.2017.11.058
M3 - Article
C2 - 29402454
AN - SCOPUS:85041355511
SN - 0022-3476
VL - 195
SP - 140-147.e1
JO - Journal of Pediatrics
JF - Journal of Pediatrics
ER -